EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Association of Epigenetic Markers of Aging With Prevalent and Incident Type 2 Diabetes

Danmeng Lily Li, Allison M Hodge, Melissa C Southey, Graham G Giles, Pierre-Antoine Dugué iD

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025

DOI: 10.1093/gerona/glaf085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Danmeng Lily Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Aging, Epigenesis, Genetic, DNA Methylation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Melbourne Collaborative Cohort Study, Wellcome Trust, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes (T2D) is characterized by elevated levels of metabolic and inflammatory markers but less is known about other molecular alterations that occur with aging. We aimed to assess the associations of DNA methylation-based measures of aging (epigenetic aging) with prevalent and incident T2D in a large sample of middle-aged and older Australians.

Methods

We used data from 5 403 participants in the Melbourne Collaborative Cohort Study (mean age = 59 years). Five blood-based epigenetic aging measures: PCPhenoAge, PCGrimAge, DNAmFitAge, bAge, and DunedinPACE were calculated. T2D status was assessed at baseline (1990–1994, Ncases = 180) and 2 waves of follow-up (1995–1998, Ncases = 134; 2003–2007, Ncases = 244). Modified Poisson regression models were used to estimate risk ratios for the associations of epigenetic age with prevalent and incident T2D.

Results

A standard deviation increase in epigenetic age was associated with 1.11-fold (PCPhenoAge, 95%CI: 0.98–1.26) to 1.33-fold (bAge, 95%CI: 1.12–1.57) higher prevalence of T2D at baseline. Prospectively, DunedinPACE showed the strongest association with incident T2D at follow-up 2 (risk ratio = 1.22, 95%CI: 1.07–1.38). These estimates were slightly attenuated but consistent in sensitivity analyses reclassifying participants who reported being T2D-free but had high glucose concentrations (> 7 mmol/L for fasting glucose, > 11.1 mmol/L for nonfasting glucose). No evidence of increased epigenetic age was found for participants with pre-T2D (> 5.6 mmol/L for fasting glucose, > 7.8 mmol/L for nonfasting glucose). The positive associations between epigenetic age and fasting glucose levels appeared stronger in participants with T2D.

Conclusions

In middle-aged and older Australians, epigenetic age, in particular as assessed by bAge and DunedinPACE, was positively associated with prevalent and incident T2D. Our findings may have implications for understanding the etiology and management of T2D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2AgingEpigenesis, GeneticDNA MethylationHumansMaleFemaleMiddle AgedAgedPrevalenceIncidenceAustraliaBiomarkersCohort Studies

Stichwörter der Autor:innen

Biological agingEpigenetic agingIncident type 2 diabetesRisk factors

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
  • Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  • Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
  • Department of Clinical Pathology, The University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Pierre-Antoine Dugué

Förderung

  • Melbourne Collaborative Cohort Study
  • Wellcome Trust
  • National Health and Medical Research Council

Zitieren

APA

Li, D. L., Hodge, A. M., Southey, M. C., Giles, G. G., & Dugué, P. A. (2025). Association of Epigenetic Markers of Aging With Prevalent and Incident Type 2 Diabetes. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glaf085

Vancouver

Li DL, Hodge AM, Southey MC, Giles GG, Dugué PA. Association of Epigenetic Markers of Aging With Prevalent and Incident Type 2 Diabetes. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glaf085

BibTeX
@article{Li2025,
  author = {Li, Danmeng Lily and Hodge, Allison M and Southey, Melissa C and Giles, Graham G and Dugué, Pierre-Antoine},
  title = {Association of Epigenetic Markers of Aging With Prevalent and Incident Type 2 Diabetes},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2025},
  doi = {10.1093/gerona/glaf085}
}
Kostenlos starten →